Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury.
Melin N, Sánchez-Taltavull D, Fahrner R, Keogh A, Dosch M, Büchi I, Zimmer Y, Medová M, Beldi G, Aebersold DM, Candinas D, Stroka D.
Melin N, et al. Among authors: keogh a.
Cell Death Dis. 2021 Apr 6;12(4):366. doi: 10.1038/s41419-021-03654-3.
Cell Death Dis. 2021.
PMID: 33824326
Free PMC article.